Paroxysmal Nocturnal Hemoglobinuria

It is now the first anti-complement therapy authorised in India for the treatment of for atypical Haemolytic Uremic Syndrome(aHUS)…

Eculizumab is approved in India to manage two rare diseases- Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Hemolytic…